<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Skou Clancy | Activity</title>
	<link>https://brycefoster.com/members/wristhandle36/activity/</link>
	<atom:link href="https://brycefoster.com/members/wristhandle36/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Skou Clancy.</description>
	<lastBuildDate>Tue, 28 Apr 2026 12:50:09 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c68f4dadca52ed3da6f583fd98a9aa40</guid>
				<title>Skou Clancy posted an update: Navigating GLP-1 Therapy: A Comprehensive Guide to Dosage and [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1522090/</link>
				<pubDate>Sun, 05 Apr 2026 17:15:38 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating GLP-1 Therapy: A Comprehensive Guide to Dosage and Availability in Germany</p>
<p>The landscape of metabolic health treatment has gone through a paradigm shift with the introduction of Glucagon-like Peptide-1 (GLP-1) receptor agonists. In Germany, these medications&#8211; initially created to handle Type 2 Diabetes Mellitus&#8211; have actually&hellip;<span class="activity-read-more" id="activity-read-more-1522090"><a href="https://brycefoster.com/activity/p/1522090/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bb8531b695370b5eb6f4be0a0a7b0132</guid>
				<title>Skou Clancy became a registered member</title>
				<link>https://brycefoster.com/activity/p/1522070/</link>
				<pubDate>Sun, 05 Apr 2026 17:12:17 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>